sellWeak cluster of 210b5-1 plan
Maiken Keson-Brookes sold $5,352 of MURA
See Remarks at Mural Oncology plc. 2,158 shares at an average of $2.48, traded Jul 18, 2025, filed Jul 22, 2025.
Warning score
3Value
$5,352
2,158 shares
Holdings after
71,406
-3% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- 0Trade size$5k at market
- 0Share of holdings soldSold 2.9% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-25-097599, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 18, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -2,158 | $2.48 | $5,352 | 71,406 | Jul 22, 2025 |
Related signals
Other insiders at Mural Oncology plc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | Mural Oncology plc | Adam D. Cutler Chief Financial Officer | $15k 7,148 shares | -7% | |
| 3Weak | Mural Oncology plc | Vicki L Goodman Chief Medical Officer | $10k 5,036 shares | -6% | |
| 0Weak | Mural Oncology plc | Maiken Keson-Brookes See Remarks | $6,379 2,572 shares | -4% | |
| 18Weak | Mural Oncology plc | Caroline Loew Chief Executive Officer | $30k 12,531 shares | -4% | |
| 3Weak | Mural Oncology plc | Maiken Keson-Brookes See Remarks | $9,308 2,731 shares | -4% | |
| 15Weak | Mural Oncology plc | Vicki L Goodman Chief Medical Officer | $51k 13,186 shares | -19% | |
| 3Weak | Mural Oncology plc | Maiken Keson-Brookes See Remarks | $8,355 2,555 shares | -6% | |
| 13Weak | Mural Oncology plc | Caroline Loew Chief Executive Officer | $9,394 2,763 shares | -1% | |
| 3Weak | Mural Oncology plc | Vicki L Goodman Chief Medical Officer | $17k 5,069 shares | -7% | |
| 15Weak | Mural Oncology plc | Adam D. Cutler Chief Financial Officer | $25k 7,421 shares | -9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.